Talmage Egan

Talmage D. Egan
OccupationsPhysician, anesthesiologist, academic, entrepreneur, and author
Academic background
EducationB.A., and M.D.
Alma materBrigham Young University
University of Utah School of Medicine
Academic work
InstitutionsStanford University, Department of Anesthesiology, University of Utah, Department of Anesthesiology, and Imperial College London

Talmage D. Egan is an American anesthesiologist, clinical scientist, and academic leader. He is a professor and the former chair of the Department of Anesthesiology at the University of Utah Health Sciences Center. Egan is recognized for his expertise in total intravenous anesthesia (TIVA) and contributions to clinical practice, training, and research in anesthesiology.[1]

Egan's research interests revolve around clinical pharmacology investigative methods applied to the development and understanding of novel intravenous anesthetics and opioids, optimal anesthetic drug administration regimens, computer controlled drug delivery and anesthetic drug interactions.[2][3][4][5]

Education

In 1978, Egan graduated from Olympus High School in Salt Lake City. Subsequently, he enrolled at Brigham Young University and completed his undergraduate studies in the humanities. He attended medical school at the University of Utah School of Medicine, graduating in 1986. After completing a preliminary residency in general surgery at the University of Utah in 1988, he pursued postgraduate training in anesthesiology, which he began at the University of Utah and completed at Stanford University in 1991. Following residency, he also completed a fellowship in clinical pharmacology at Stanford. Egan took sabbatical as a visiting scientist at the Imperial College in London, UK in 2000, studying using functional magnetic resonance techniques.[1]

Career

Egan started his academic career as a clinical instructor and assistant professor for the department of anesthesiology at Stanford University. He relocated to the University of Utah as an assistant professor in 1993, eventually becoming professor. Since 2004, he has been a professor of anesthesiology, with adjunct positions in the departments of pharmaceutics, bioengineering, and neurosurgery. Egan served as president of the medical staff and chair of the medical board at the University of Utah Health Sciences Center from 2006 to 2008.[6]

Egan became chair of the Department of Anesthesiology at the University of Utah Health Sciences Center in 2015.[7] During his tenure, he oversaw significant growth of the department, expanded clinical training programs, and strengthened its research portfolio. He was succeeded by Grace Lim in 2026.[8]

His clinical practice focused primarily on obstetrical and neuroanesthesia; he served as the chief of neuroanesthesia at the University of Utah for over 10 years.[6]

Egan is the principal creator of Safe Sedation Training (SST), a virtual preceptorship for training non-anesthesia professionals in procedural sedation.[9] He is a founding owner of a medical education and consulting company.[10] Egan has trademarks and patents in connection with this work.[11]

Egan served as an associate editor of the scientific journal Anesthesiology from 1999 to 2005 and as associate editor of the British Journal of Anaesthesia.[12]

Egan has lectured on intravenous anesthesia techniques and concepts in the US and internationally, including honorary and keynote lectures (see Awards and Honors).[1]  For example, he has participated in academic events such as serving as a guest judge and lecturer at Duke University’s annual academic evening[13], and also numerous visiting professorships at institutions such as Harvard, Cornell, the Karolinska Institute, and Washington University.[14]

Research

Egan has authored over 150 publications.[2][15] A significant part of Egan's work has been focused on drug interactions and computer controlled drug delivery systems. He has worked on developing various methods of total intravenous anesthesia (TIVA),[16] has demonstrated the clinical use of the short acting opioid remifentanil, and defined interactions between intravenous anesthetics i.e., propofol and opioids.[17][18] Much of his research focuses on the pharmacological and therapeutic principles of sedatives and analgesic drugs.[19][16]

He has been recognized internationally for his work on the development and clinical application of the short acting opioid remifentanil and its interaction with intravenous hypnotics such as propofol, contributing to improved drug delivery regimens and patient safety practices in anesthesia.[17]

Egan’s investigations have developed remifentanil propofol interaction models to predict responsiveness and reaction to surgical stimuli during anesthesia, helping to refine anesthesia dosing and improve clinical outcomes.[18] These studies include assessments of remifentanil propofol response surface models in patients undergoing elective surgery, demonstrating the predictive value and limitations of propofol-opioid interaction models.[20]

Egan’s scholarly output includes editorials and reviews that articulate conceptual advances in anesthetic drug delivery, such as discussions on multimodal general anesthesia and the central role of opioid based strategies within balanced anesthesia paradigms. His prize winning textbook on anesthetic pharmacology and physiology, Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application, has been recognized by professional bodies and has contributed to education in the field.[21]

Later in his career, working with Stanford colleagues Drs. Thomas Schnider (Switzerland) and Charles Minto (Australia), Egan contributed to the development of a novel concept in anesthesia clinical pharmacology known as the “drug titration paradox,” a concept that has important implications for anesthesia pharmacology research.[22]

Collectively, Egan’s research has influenced both theoretical understanding and practical management of anesthetic drug administration, particularly in TIVA techniques involving remifentanil, pharmacokinetic modeling of anesthetic interactions, and the optimization of sedation and analgesia in perioperative care.[23]

Personal life

Egan married Julie Cook in 1984. They have five children. He is a member of the Church of Jesus Christ of Latter-day Saints (LDS) and served as a volunteer missionary in Sendai, Japan, from 1979 to 1981.[24] He later served as a lay pastor (bishop) of a University of Utah LDS student congregation from 2011 to 2014.[25]He has published numerous essays relating to his faith in various LDS forums.[26]

Awards and honors

  • 1997 - Teaching Recognition Award, International Anesthesia Research Society[27]
  • 1998 – FAER/Roche Pharmaceuticals Clinical Research Award, Foundation for Anesthesia Education & Research
  • 2001 – Jan Kukral Distinguished Lecturer Award, Northwestern University School of Medicine
  • 2003 – Ralph M. Waters Visiting Professor, University of Wisconsin Medical School
  • 2010 – Ellis Gillespie Keynote Lecturer Award, Australian-New Zealand College of Anaesthetists
  • 2016 – Lifetime Achievement Award, International Society for Anaesthetic Pharmacology[28]
  • 2019 – Highly Commended Book Award, British Medical Association[29]
  • 2022 – Mohamed Naguib Honorary Lecturer, International Society of Anaesthetic Pharmacology
  • 2022 – 52nd Annual E.A. Rovenstine Memorial Lecturer, New York State Society of Anesthesiologists

Bibliography

Books

  • Anesthesia for the New Millennium (1999) ISBN 978079235632-5
  • Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application (2013) ISBN 9781437716795
  • Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application 2nd Edition (2019) ISBN 9780323481106
  • Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application 3rd Edition (2026)[30]

Selected articles

References

  1. 1 2 3 "Celebrating the Past, Present, and Future of Anesthesiology". University of Utah Health | University of Utah Health. June 2, 2022.
  2. 1 2 "Talmage Egan". scholar.google.com.
  3. ↑ Mahmoud, Mohamed; Mason, Keira P. (April 17, 2018). "Recent advances in intravenous anesthesia and anesthetics". F1000Research. 7: F1000 Faculty Rev–470. doi:10.12688/f1000research.13357.1. PMC 5911929. PMID 29755731.
  4. ↑ "Past Presidents". www.isaponline.org.
  5. ↑ Egan, Talmage D.; Weiskopf, Richard B. (2003-11-01). "Target-Controlled Drug Delivery". Anesthesiology. 99 (5): 1214–1219. doi:10.1097/00000542-200311000-00031. ISSN 0003-3022. PMID 14576561.
  6. 1 2 "U of U Health". healthcare.utah.edu.
  7. ↑ "Talmage Egan". Deseret News. 2025-05-15. Retrieved 2026-03-20.
  8. ↑ Cortigiano, Cameron (2026-02-26). "U of Utah anesthesia chair to step down". Becker’s ASC. Retrieved 2026-03-20.
  9. ↑ "Safe Sedation Training is Driven by Experience and Expertise".
  10. ↑ "Medvis-About".
  11. ↑ US8744779B2, Syroid, Noah; Westenskow, Dwayne R. & Agutter, James et al., "Methods and apparatus for drug modeling and displaying drug models", issued 2014-06-03
  12. ↑ "British Journal of Anaesthesia - Editorial Board".
  13. ↑ Communication, Marketing and (2023-07-05). "Dr. Egan Served as Guest Judge at Duke's 31st Annual Academic Evening | Anesthesiology Department | U of U School of Medicine". medicine.utah.edu. Retrieved 2026-03-20.
  14. ↑ "Talmage D. Egan | University of Utah Health". healthcare.utah.edu. 2026-02-02. Retrieved 2026-03-20.
  15. ↑ "Talmage D. Egan – ResearchGate Profile".
  16. 1 2 Egan, Talmage D. (June 16, 2015). "Total intravenous anesthesia versus inhalation anesthesia: a drug delivery perspective". Journal of Cardiothoracic and Vascular Anesthesia. 29 (Suppl 1): S3–6. doi:10.1053/j.jvca.2015.01.024. PMID 26025044.
  17. 1 2 Egan, T. D. (August 16, 2000). "Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000". Current Opinion in Anesthesiology. 13 (4): 449–455. doi:10.1097/00001503-200008000-00009. PMID 17016340.
  18. 1 2 Egan, Talmage D. (June 16, 2019). "Are opioids indispensable for general anaesthesia?". British Journal of Anaesthesia. 122 (6): e127–e135. doi:10.1016/j.bja.2019.02.018. PMID 31104756. S2CID 133023216.
  19. ↑ "Target-controlled Infusions for Intravenous Anesthetics: Surfing USA Not!".
  20. ↑ "Editorial introductions". Current Opinion in Anaesthesiology. 36 (4): v–vi. August 2023. doi:10.1097/ACO.0000000000001276. ISSN 0952-7907.
  21. ↑ "2019 BMA Medical Book Awards Winners". www.eu.elsevierhealth.com. Retrieved 2026-03-20.
  22. ↑ Egan, Talmage D. (2022). "The drug titration paradox: something obvious finally understood". British Journal of Anaesthesia. 128 (6): 900–902. doi:10.1016/j.bja.2022.03.007. ISSN 0007-0912. PMID 35397881.
  23. ↑ Egan, Talmage D. (2018). "An Intellectual Framework for Drug Administration Methods in Anesthesia: Three Practice Domains". Anesthesia and Analgesia. 127 (4): 817–819. doi:10.1213/ANE.0000000000003601. ISSN 1526-7598. PMID 30216285.
  24. ↑ "Elder Talmage D. Egan".
  25. ↑ "Pictures: 2007 - President and Sister Sakai with Talmage Egan in 2007 South of Tokyo in 2007".
  26. ↑ Egan, Talmage D. (2024-02-05). "A New Approach to Ministering to Those Who've Lost Faith". Public Square Magazine. Retrieved 2026-03-20.
  27. ↑ "Teaching Recognition Awards".
  28. ↑ "ISAP Lifetime Achievement Award". www.isaponline.org.
  29. ↑ "Talmage Egan, MD, Department Chair receives Highly Commended award for "Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application" from the British Medical Association". Anesthesiology Department | U of U School of Medicine. September 3, 2019.
  30. ↑ "Pharmacology and Physiology for Anesthesia - 9780443107160". MEA Elsevier Health. Retrieved 2026-03-20.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.